Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals

The prognostic impact of direct‐acting antivirals (DAAs) on patients with hepatitis C‐related hepatocellular carcinoma (C‐HCC) is still unclear. This study aimed to evaluate the prognosis of C‐HCC in the DAA era. We enrolled 1237 consecutive patients with treatment‐naive C‐HCC who underwent radical...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukumoto, Tsuyoshi, Minami, Tatsuya, Moriyama, Makoto, Yamada, Tomoharu, Wake, Taijiro, Kinoshita, Mizuki Nishibatake, Fujiwara, Naoto, Nakagomi, Ryo, Nakatsuka, Takuma, Sato, Masaya, Enooku, Kenichiro, Nakagawa, Hayato, Fujishiro, Mitsuhiro, Shiina, Shuichiro, Koike, Kazuhiko, Tateishi, Ryosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426397/
https://www.ncbi.nlm.nih.gov/pubmed/35641233
http://dx.doi.org/10.1002/hep4.2010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426397/
https://www.ncbi.nlm.nih.gov/pubmed/35641233
http://dx.doi.org/10.1002/hep4.2010

Ejemplares similares